Blepharitis is an inflammation of the eyelids in which they become red, irritated and itchy and dandruff-like scales form on the eyelashes. It is a common eye disorder caused by either bacteria or a skin condition, such as dandruff of the scalp or rosacea. It affects people of all ages. Although uncomfortable, blepharitis is usually not contagious and generally does not cause any permanent damage to eyesight.
This report contains market size and forecasts of Blepharitis Therapeutics in Global, including the following market information:
Global Blepharitis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Blepharitis Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Blepharitis Therapeutics include Bausch Health, Allergan, Novartis, LABORATORIES THEA, Akorn, NovaBay Pharmaceuticals and Scope Ophthalmics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blepharitis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blepharitis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Blepharitis Therapeutics Market Segment Percentages, by Type, 2021 (%)
Antibiotics
Steroids
Other
Global Blepharitis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Blepharitis Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Other
Global Blepharitis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Blepharitis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blepharitis Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Blepharitis Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health
Allergan
Novartis
LABORATORIES THEA
Akorn
NovaBay Pharmaceuticals
Scope Ophthalmics